VEGFA and prostate cancer: Correlations between quantitative DCE-MRI-parameters and direct tissue-based biomarkers of angiogenesis, such as vascular endothelial growth factor (VEGF) and MVD have been studied in several malignancies, including in prostate cancer, with varying results22,25–32.